MASH
Clinical trials for MASH explained in plain language.
Never miss a new study
Get alerted when new MASH trials appear
Sign up with your email to follow new studies for MASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New MASH drug enters early human testing – could it ease fatty liver?
Disease control Not yet recruitingThis early-stage study tests a new drug called OPK-88006 in healthy volunteers and people with MASH, a serious fatty liver condition. The main goals are to check safety, how the drug moves through the body, and early signs it might help the liver. About 30 participants will take …
Matched conditions: MASH
Phase: PHASE1, PHASE2 • Sponsor: OPKO Health, Inc. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Gut implant shows promise for diabetes and obesity control
Disease control Not yet recruitingThis study tests a new device called the Trans-Duodenal Barrier, a temporary implant placed in the upper small intestine for 6 months. It aims to lower blood sugar (HbA1c) and help with weight loss in adults with type 2 diabetes and obesity. Researchers will also check if it impr…
Matched conditions: MASH
Phase: NA • Sponsor: Trans-Duodenal Concepts GmbH • Aim: Disease control
Last updated May 13, 2026 16:02 UTC